The pursuit of growth can make investors do odd things.
Joined the team in 2012
What do you do when one of the world’s oldest, highest quality markets is treated like a developing one?
'Plenty of false dawns' along the way
Value stocks may have enjoyed a welcome change in fortunes in recent weeks, but they have been swimming against the tide for years as investors have sought the perceived security of quality and low-volatility stocks.
Disrupters, tech leaders and global-facing stocks
Late stage of the IPO cycle
Boris Johnson's arrival at Number 10 has done little to enhance UK investor confidence; he has wasted no time setting a collision course with the EU over his no-deal strategy, and members on the other side of the House of Commons.
Brexit uncertainty continues to act as a drag on the UK economy, holding back business investment and undermining consumer confidence.
The long-term attraction of the UK smaller companies market is beyond doubt.
Never catch a falling knife. Helpful health and safety advice but, in an equity market context, does the idea of not buying shares in companies that have seen a material price decline really help one make money over the long term?
There can be no doubt the protracted Brexit debacle in the UK is casting a long shadow over its investment markets.
Can British companies still prosper after Brexit?
Portfolio is now '100% as desired'
We see far too many examples of management teams across 'UK plc' failing to act in the interests of the stakeholders of the companies they are employed to run.
The UK economy continues to grow. However, ongoing wrangling over our exit from Europe and broader domestic political uncertainty has seen growth expectations reduced to a rather uninspiring 1.2% in 2019, according to official forecasters.
Which funds made the cut?
Improved business investment
While we are stock-pickers, we do not ignore the business cycle; analysing it helps us determine when to allocate capital to certain companies.
A troubled Brexit with Parliamentary stumbles and deadline extensions, while the original departure date has come and gone.
When it comes to finding growth in the UK, we are positive on the pharmaceuticals sector.
UK equities had a positive start to 2019. While this can be partly viewed as a rebound after 2018's difficult final quarter, what is likely to have been most significant is an extraordinary U-turn by the US Federal Reserve.
Brexit continues to dominate the headlines, with the overall prognosis no clearer.
We are all tired of talking about backstops and customs unions and voting blocs, but Brexit chat still manages to get centre stage to the exclusion of all else.